TIDMBRH

RNS Number : 6969X

Braveheart Investment Group plc

22 December 2023

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

22 December 2023

Braveheart Investment Group Plc

("Braveheart", the "Company" or the "Group")

Proposed sale of Phasefocus

Braveheart Investment Group (AIM: BRH), is pleased to announce the conditional sale of Phasefocus Holdings Limited ("Phasefocus") to Bruker UK Limited ("Bruker"), a global analytical instrumentation company, for a consideration of GBP5 million (the "Sale").

The shareholders of Phasefocus ("Phasefocus Shareholders"), including Braveheart, have on 21 December 2023, entered into a conditional sale and purchase agreement (the "Agreement") with Bruker, pursuant to which Bruker will acquire 100% of the share capital of Phasefocus. Completion of the Sale is subject to customary closing conditions being satisfied and the granting of probate relating to a deceased Phasefocus Shareholder and is therefore expected to take place in Q1 2024.

The total consideration for the Sale will be payable in cash, subject to customary adjustments for working capital, cash, debt and transaction costs and represents a Sale price of GBP17.74 per Phasefocus share. Braveheart holds 48.3% of the issued share capital of Phasefocus and the Board of Braveheart estimates that the total proceeds receivable by the Company for the Sale will be approximately GBP2.1 million (after expenses).

Phasefocus' imaging and analysis system, Livecyte(R), uses a novel patented method for high fidelity quantitative imaging and microscopy. In the year ended 31 December 2022, Phasefocus incurred a loss before taxation of GBP990,854. This loss was incurred due to the write down of a loan with its 100% owned trading subsidiary, Phase Focus Limited. The trading loss after tax of Phase Focus Limited was limited to GBP361,634 in the year ending 31 December 2022.

The book value of Braveheart's investment in Phasefocus as at 31 March 2023 was GBP2.5 million. On 21 August 2023, Braveheart announced it had purchased an additional 18,750 new ordinary shares in Phasefocus at a price of GBP8 per share for a total consideration of GBP150,000.

Following completion of the Sale, the Braveheart Board will consider whether the proceeds should be applied towards furthering the Company's strategy of investing in and growing technology-based companies in line with the investing strategy or whether to distribute the proceeds to shareholders via a special dividend. A further update will be provided on this in due course.

A further announcement will be made on completion of the Sale.

For further information:

 
 Braveheart Investment Group plc              Tel: 01738 587555 
 Trevor Brown, Chief Executive Officer 
  Viv Hallam, Executive Director 
 Allenby Capital Limited (Nominated Adviser   Tel: 020 3328 5656 
  and Joint Broker) 
 James Reeve / George Payne 
 
 Peterhouse Capital Limited (Joint Broker)    Tel: 020 7469 0936 
 Duncan Vasey / Lucy Williams

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFUZZMZZMMRGFZZ

(END) Dow Jones Newswires

December 22, 2023 02:00 ET (07:00 GMT)

Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos Braveheart Investment.
Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos Braveheart Investment.